Kusajili – Clinical trials directory

Result of your search per specialist: Prof Michel Marty

Woman Max 99 years
Support from Sanofi-Aventis, Roche Pharma and Pfizer Update Il y a 4 ans

A randomised phase II study of cytotoxic chemotherapy or cytotoxic chemotherapy combined with celecoxib or trastuzumab as primary chemotherapy for patients with high risk localised breast cancer not amenable to breast conserving therapy Not provided at time of registration

Country France
organs None
Specialty None

Closed trial

More information